Making a therapeutic choice: human versus recombinant fractions - can we do it?-Reference-Cited by-同舟云学术

Making a therapeutic choice: human versus recombinant fractions - can we do it?

Published:2001-01 Issue: Volume:7 Page:1-3
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

Aledort L.M.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2516.2001.00095.x/fullpdf

Reference10 articles.

1. BPL factor XI concentrate: clinical experience in the USA.;Aledort;Haemophilia,1997

2. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A.;Schwartz;N Engl J Med,1990

3. A multicenter study of recombinant factor VIII (Recombinate): Safety, efficacy and inhibitor risk in previously untreated patients with hemophilia A.;Bray;Blood,1994

4. Inhibitors in hemophilia patients: current status and management.;Aledort;Am J Hematol,1994

5. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations.;Donegan;Ann Intern Med,1990

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity;Thrombosis Research;2015-05

2. Efficacy of factor IX Grifols® in surgery: experience of an international multicentre retrospective study;Haemophilia;2012-07-30

3. Therapeutic properties and safety of recombinant factor VIII and factor IX;Polish Archives of Internal Medicine;2009-06-01

4. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain;Blood Coagulation & Fibrinolysis;2008-07

5. Psychosocial Functioning Problems Over Time Among High-Risk Youths;Crime & Delinquency;2007-12-20